1型糖尿病患者与一般人群匹配对照的心房颤动风险:一项前瞻性病例对照研究
在瑞典国家糖尿病登记中,36 258例1型糖尿病患者按年龄、性别和居住县与179 980名对照匹配,随访至2013年12月31日。调整后心房颤动风险在男性为HR 1.13(95%CI 1.01-1.25),女性为HR 1.50(95%CI 1.30-1.72),性别交互P=0.0019;风险随血糖控制恶化和肾脏并发症增加。
要点
- 1型糖尿病男性心房颤动风险轻度升高,HR 1.13(95%CI 1.01-1.25)。
- 1型糖尿病女性心房颤动风险升高50%,HR 1.50(95%CI 1.30-1.72)。
- 正常白蛋白尿者中,HbA1c低于9.7%的男性和低于8.8%的女性无超额心房颤动风险。
核心结论
- 与一般人群相比,1型糖尿病男性心房颤动风险轻度升高,女性升高50%。
- 1型糖尿病患者的心房颤动风险随肾脏并发症和血糖控制恶化而增加。
研究设计与样本
- 前瞻性病例对照研究,1型糖尿病病例来自瑞典国家糖尿病登记,每例按年龄、性别和居住县匹配5名从瑞典人口登记随机选取的对照。
- 随访36 258例1型糖尿病患者和179 980名对照,时间为2001年1月1日至2013年12月31日。
- 心房颤动病例来自瑞典国家患者登记。
- 患者中位随访9.7年(IQR 5.2-13.0),对照中位随访10.2年(IQR 5.7-13.0)。
主要发现
- 749例(2%)1型糖尿病患者和2882例(2%)对照被诊断为心房颤动。
- 调整后风险比:男性HR 1.13(95%CI 1.01-1.25;p=0.029),女性HR 1.50(95%CI 1.30-1.72;p<0.0001),性别交互p=0.0019。
- 1型糖尿病患者的超额心房颤动风险随血糖控制恶化和肾脏并发症增加。
- 在正常白蛋白尿者中,HbA1c低于9.7%(<83 mmol/mol)的1型糖尿病男性和HbA1c低于8.8%(<73 mmol/mol)的1型糖尿病女性未观察到心房颤动超额风险。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Type 1 diabetes is associated with an increased risk of developing several cardiovascular complications. To our knowledge, the independent association between type 1 diabetes and atrial fibrillation has not been studied. METHODS: We did a prospective case-control study of individuals with type 1 diabetes in the Swedish National Diabetes Registry who were each matched with five controls for age, sex, and county of residence who were randomly selected from the Swedish Population Register. Cases of atrial fibrillation were obtained from the Swedish National Patient Registry. FINDINGS: We followed up 36 258 patients with type 1 diabetes and 179 980 controls between Jan 1, 2001, and Dec 31, 2013. Median follow-up was 9·7 years (IQR 5·2-13·0) for patients and 10·2 years (5·7-13·0) for controls. 749 (2%) individuals with type 1 diabetes and 2882 (2%) controls were diagnosed with atrial fibrillation, with an adjusted hazard ratio (HR) of 1·13 (95% CI 1·01-1·25; p=0·029) in men and 1·50 (1·30-1·72; p<0·0001) in women (p=0·0019 for interaction). The excess risk of atrial fibrillation in individuals with type 1 diabetes increased with worsening glycaemic control and renal complications. Among individuals with normoalbuminuria, no excess risk of atrial fibrillation was noted in men with type 1 diabetes who had HbA1c lower than 9·7% (<83 mmol/mol) or in women with type 1 diabetes who had HbA1c lower than 8·8% (<73 mmol/mol). INTERPRETATION: Compared with the general population, the risk of atrial fibrillation in men with type 1 diabetes was slightly raised, whereas for female patients it was 50% higher. The risk of atrial fibrillation in people with type 1 diabetes increased with renal complications and poor glycaemic control. FUNDING: Novo Nordisk Foundation, Swedish State (ALF agreement), Swedish Research Council (SIMSAM), Swedish Heart and Lung Foundation, Swedish Diabetes Foundation, Diabetes Wellness.
引用
- Dahlqvist S, Rosengren A, Gudbjörnsdottir S, et al. Risk of atrial fibrillation in people with type 1 diabetes compared with matched controls from the general population: a prospective case-control study. Lancet Diabetes Endocrinol. 2017. PMID: 28838683. doi:10.1016/S2213-8587(17)30262-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。